Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study--NCIC CTG MA.5. (Q46681069)
Jump to navigation
Jump to search
scientific article published in September 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study--NCIC CTG MA.5. |
scientific article published in September 2005 |
Statements
1 reference
Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study--NCIC CTG MA.5. (English)
1 reference
National Cancer Institute of Canada Clinical Trials Group
1 reference
Wendy R Parulekar
1 reference
Andrew G Day
1 reference
Jon A Ottaway
1 reference
Lois E Shepherd
1 reference
Maureen E Trudeau
1 reference
Vivien Bramwell
1 reference
Mark Levine
1 reference
Kathleen I Pritchard
1 reference
1 September 2005
1 reference
1 reference
23
1 reference
25
1 reference
6002-6008
1 reference
Identifiers
1 reference
1 reference